JBTKJHVACZKBRW-IADCTJSHSA-N
C30H25F6N7O3S — CID 142455397
Data last refreshed: (MolForge compound catalog, from PubChem)
About JBTKJHVACZKBRW-IADCTJSHSA-N
JBTKJHVACZKBRW-IADCTJSHSA-N (PubChem CID 142455397) has the molecular formula C30H25F6N7O3S and a molecular weight of 677.63 g/mol. Its IUPAC name is N-[(4aS,6S)-1-(4-fluorophenyl)-4a-[4-(trifluoromethyl)pyridine-2-carbonyl]-5,6,7,8-tetrahydro-4H-benzo[f]indazol-6-yl]-N-cyclopropyl-2-(difluoromethyl)triazole-4-sulfonamide.
Molecular Properties
| Compound Name | JBTKJHVACZKBRW-IADCTJSHSA-N |
|---|---|
| PubChem CID | 142455397 |
| Molecular Formula | C30H25F6N7O3S |
| Molecular Weight | 677.63 g/mol |
| Exact Mass | 677.16 |
| IUPAC Name | N-[(4aS,6S)-1-(4-fluorophenyl)-4a-[4-(trifluoromethyl)pyridine-2-carbonyl]-5,6,7,8-tetrahydro-4H-benzo[f]indazol-6-yl]-N-cyclopropyl-2-(difluoromethyl)triazole-4-sulfonamide |
| SMILES | O=C(c1cc(C(F)(F)F)ccn1)[C@]12Cc3cnn(-c4ccc(F)cc4)c3C=C1CC[C@H](N(C1CC1)S(=O)(=O)c1cnn(C(F)F)n1)C2 |
| InChI | InChI=1S/C30H25F6N7O3S/c31-20-2-5-21(6-3-20)41-25-12-18-1-4-23(42(22-7-8-22)47(45,46)26-16-39-43(40-26)28(32)33)14-29(18,13-17(25)15-38-41)27(44)24-11-19(9-10-37-24)30(34,35)36/h2-3,5-6,9-12,15-16,22-23,28H,1,4,7-8,13-14H2/t23-,29-/m0/s1 |
| InChIKey | JBTKJHVACZKBRW-IADCTJSHSA-N |
| XLogP | 5.63 |
| TPSA | 115.87 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 677.63 |
| LogP ≤ 5 | 5.63 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142455397 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.